CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells-Reference-Cited by-同舟云学术

CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells

Published:2021-04-16 Issue: Volume: Page:
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Marayati Raoud^ORCID,Stafman Laura L.,Williams Adele P.,Bownes Laura V.,Quinn Colin H.^ORCID,Markert Hooper R.^ORCID,Easlick Juliet L.,Stewart Jerry E.,Crossman David K.^ORCID,Mroczek-Musulman Elizabeth,Beierle Elizabeth A.^ORCID

Funder

Cannonball Kids cancer, Sid Strong Foundation, Elaine Roberts Foundation, Open Hands Overflowing Hearts, and Starr Fund-Vince Lombardi Cancer Foundation.

U.S. Department of Health & Human Services | NIH | National Cancer Institute

Society of University Surgeons Foundation

U.S. Department of Health & Human Services | National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/s41417-021-00334-4.pdf

Reference60 articles.

1. Feng J, Polychronidis G, Heger U, Frongia G, Mehrabi A, Hoffmann K. Incidence trends and survival prediction of hepatoblastoma in children: a population-based study. Cancer Commun (Lond). 2019;39:62.

2. Zhang X, Song M, Kundu JK, Lee MH, Liu ZZ. PIM kinase as an executional target in cancer. J Cancer Prev. 2018;23:109–16.